![[current-page:title] logo](/sites/default/files/styles/logo/public/default_images/_no-logo.png?itok=8OH0tuUw){kind=logo}
Founded
Address
Elixir Pharmaceuticals Inc
12 Emily Street
Cambridge, MA 02139
United States
Phone
Sector
KANDO id: 127999
Corporate information
Official name
Elixir Pharmaceuticals Inc
Registration country
Official identities
US CIK 0001175784
Funding rounds
Series C
( )
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
CDIB Ventures | Initial investment. | ||
|
JAFCO Ventures Inc | Initial investment. | ||
|
MPM Capital | Initial investment. | ||
|
Oxford Bioscience Partners (OBP) | Initial investment. | ||
|
|
YFY Biotech Management Co | Initial investment. |
| Investor | Profile | Country | |
|---|---|---|---|
|
ARCH Venture Partners LP | Venture capital firm providing seed and early stage capital, with a special expertise in co-founding and building technology firms from startup |
| Investor | Profile | Country | |
|---|---|---|---|
|
Hercules Technology Growth Capital Inc | Specialised finance company providing debt and equity growth capital to technology-related companies at all stages of development. |
| Investor | Profile | Country | |
|---|---|---|---|
|
Globespan Capital Partners | Global venture capital firm investing in information technology companies |
Investment activity status
Active investor
Team
| Employee | Position | ||
|---|---|---|---|
| Paul Martha | Director
Responsibilities: Executive Officer |